Semaglutide vs. Tirzepatide (Ozempic vs. Mounjaro): Which GLP-1 Is Right for You?

What Are Semaglutide and Tirzepatide?

Semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (in Mounjaro and Zepbound) are injectable medications that quiet appetite and slow digestion, helping you eat less without constant hunger.

Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 agonist — it acts on two gut-hormone pathways instead of one.

How They Compare for Weight Loss

Both produce substantial weight loss well beyond diet and exercise alone. In head-to-head research, tirzepatide has tended to produce somewhat greater average weight loss, while semaglutide has a longer track record and broad availability.

For many people either medication works very well; the best choice depends on your goals, medical history, tolerance, and cost.

Side Effects and Tolerance

Both can cause nausea, especially early on, which usually eases as the dose is titrated slowly. A physician starts you low and increases gradually to minimize side effects.

How to Choose

The right medication is a clinical decision made with a provider who reviews your health history and goals. MultiGen Wellness prescribes GLP-1 therapy online and helps you start the option that fits you best.

Frequently Asked Questions

Is tirzepatide better than semaglutide?

Tirzepatide has shown somewhat greater average weight loss in studies, but semaglutide is highly effective with a longer track record. A provider helps you choose.

Do I need insurance?

No — MultiGen Wellness offers transparent cash pricing, no insurance runaround.

Can I switch between them?

Sometimes, under physician guidance, based on response and tolerance.

Ready to start? MultiGen Wellness offers physician-prescribed semaglutide weight loss by telehealth in all 50 states — medication shipped to your door, with ongoing monitoring. New patients start for $247 (regularly $497). Ask which GLP-1 fits your goals.